Antibody Drug Conjugates Market Growth Drivers, Challenges and Forecast to 2031
Antibody drug conjugates are transforming cancer treatment by combining the precision of monoclonal antibodies with the potency of cytotoxic drugs. These targeted therapies are improving treatment outcomes while minimizing damage to healthy tissues, making them an important advancement in oncology. The Antibody Drug Conjugates Market is projected to grow from US$ 8,105.65 million in 2023 to US$...
0 Comments 0 Shares 293 Views 0 Reviews
Sponsored